Načítá se...
P03.02 Ketogenic diets as an adjuvant therapy in glioblastoma (KEATING): A mixed method, randomised, feasibility study.
BACKGROUND: There is increasing interest in the use of ketogenic diets (KD) as adjuvant therapy for glioblastoma (GBM). This trial aimed to: (i) investigate protocol feasibility, (ii) measure patient and carer tolerability and (iii) inform the design of future phase III clinical trials. MATERIAL AND...
Uloženo v:
| Vydáno v: | Neuro Oncol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6144075/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.229 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|